Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-02

Clinical Trial Update: Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women [Phase 3]

View source ↗

Summary

A completed Phase 3 trial from GlaxoSmithKline evaluating the consistency and non-inferiority of the HPV vaccine Cervarix in young adult women, focusing on HPV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Papillomavirus Type 16/18 Infection, Cervical Intraepithelial Neoplasia | Phase 3 | Status: COMPLETED | Results posted: 2010-03-02